Can pulmonary fibrosis affect people of any age? 

While pulmonary fibrosis can technically occur at any stage of life, it is overwhelmingly a condition associated with older age. The most common form of the disease, idiopathic pulmonary fibrosis (IPF), is rarely seen in individuals under the age of 50 and is most frequently diagnosed in those in their 70s and 80s. However, certain other types of lung scarring can affect younger adults and even, in very rare cases, children. In the UK, the age at which symptoms appear often provides clinicians with a vital clue as to the underlying cause of the scarring, helping them to distinguish between environmental, genetic, or age-related forms of the disease. 

What We’ll Discuss in This Article 

• Why idiopathic pulmonary fibrosis is primarily a disease of older age. 

• How environmental and occupational exposures affect middle-aged adults. 

• The role of genetics in rare cases of early-onset lung scarring. 

• Why children and young people are rarely affected by this condition. 

• Age-related diagnostic trends and referral pathways in the UK. 

Prevalence in the older population 

Pulmonary fibrosis is most commonly diagnosed in people over the age of 70. This is because the most prevalent type, idiopathic pulmonary fibrosis (IPF), is believed to be linked to the natural ageing process of the lungs. IPF is very rare in people under 50 and becomes increasingly common with each decade of life. As we age, our lung cells may become less efficient at repairing minor damage from environmental factors, leading to the gradual accumulation of scar tissue. Current UK data indicates that the average age of a person at the time of their diagnosis is approximately 74 years old. 

Occupational exposure and middle age 

While the idiopathic form affects the elderly, occupational and environmental pulmonary fibrosis can often be seen in slightly younger age groups, typically those in their 50s and 60s. This is because these conditions are caused by breathing in harmful substances such as asbestos, silica, or bird proteins over many years of a working life. NICE guidance for managing idiopathic pulmonary fibrosis requires doctors to carefully investigate a patient’s work history, especially if they are younger than the typical age for IPF. If a person was exposed to high levels of industrial dust in their 20s, the resulting scarring might start to cause noticeable breathlessness three or four decades later. 

Hereditary factors and early onset 

In cases where pulmonary fibrosis is found in younger adults (those in their 40s or 50s), there is often a strong genetic or hereditary link. Familial pulmonary fibrosis can cause scarring to develop earlier than it would in the general population. These cases are often linked to mutations in genes that control “telomeres,” which are the protective caps on the ends of chromosomes. If these caps are abnormally short, the lung cells effectively “age” prematurely, leading to fibrosis at an earlier stage of life. If a person under 50 presents with signs of lung scarring, UK specialists will almost always investigate whether there is a family history of the condition. 

Pulmonary fibrosis in children 

It is extremely rare for children to develop pulmonary fibrosis. When lung scarring does occur in childhood, it is usually a very different disease compared to the adult version and is often referred to as Child Interstitial Lung Disease (ChILD). These cases are typically caused by rare genetic disorders affecting the development of the lungs or the production of surfactant, a substance that helps the air sacs stay open. Because these conditions are so distinct from adult fibrosis, children are managed by specialist paediatric respiratory centres rather than general adult lung clinics. 

Impact of age on diagnosis and treatment 

The age of the patient significantly influences how the NHS approaches the diagnostic process and subsequent treatment. In older patients, the focus is often on differentiating fibrosis from other common age-related conditions like heart failure or chronic obstructive pulmonary disease (COPD). For younger patients, the search for an underlying cause such as an autoimmune disease like rheumatoid arthritis is often more intensive. Regardless of age, the goal of treatment in the UK is to preserve as much lung function as possible and manage symptoms like cough and breathlessness to maintain the best possible quality of life. 

Conclusion 

Pulmonary fibrosis is primarily a disease of older age, with the vast majority of UK cases occurring in those over 70. However, younger adults can be affected, particularly when there is a history of workplace exposure or a genetic predisposition. While it is exceptionally rare in children, lung scarring can manifest at any age depending on the specific underlying cause. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides an overview of how age influences the prevalence and diagnosis of pulmonary fibrosis, adhering to the clinical standards of the NHS and NICE. The information is designed to help the general public understand that while age is a major factor, the condition can occasionally affect younger individuals under specific circumstances. This content was produced by a medical content team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician, to ensure clinical accuracy.